vatalanib has been researched along with krn 633 in 1 studies
| Studies (vatalanib) | Trials (vatalanib) | Recent Studies (post-2010) (vatalanib) | Studies (krn 633) | Trials (krn 633) | Recent Studies (post-2010) (krn 633) |
|---|---|---|---|---|---|
| 276 | 42 | 98 | 31 | 0 | 25 |
| Protein | Taxonomy | vatalanib (IC50) | krn 633 (IC50) |
|---|---|---|---|
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 4.33 | |
| Platelet-derived growth factor receptor alpha | Homo sapiens (human) | 0.97 | |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.0855 | |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.125 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.0805 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
1 other study(ies) available for vatalanib and krn 633
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |